Case ReportClinical Sciences
A New Imaging Agent for Medullary Carcinoma of the Thyroid
Hitoya Ohta, Kazutaka Yamamoto, Keigo Endo, Toru Mori, Daisaburo Hamanaka, Akira Shimazu, Katsuji Ikekubo, Kazuo Makimoto, Yasuhiro Lida, Junji Konishi, Rikushi Morita, Naotaka Hata, Kazuko Horiuchi, Akira Yokoyama, Kanji Torizuka and Kanji Kuma
Journal of Nuclear Medicine March 1984, 25 (3) 323-325;
Hitoya Ohta
Kazutaka Yamamoto
Keigo Endo
Toru Mori
Daisaburo Hamanaka
Akira Shimazu
Katsuji Ikekubo
Kazuo Makimoto
Yasuhiro Lida
Junji Konishi
Rikushi Morita
Naotaka Hata
Kazuko Horiuchi
Akira Yokoyama
Kanji Torizuka


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
A New Imaging Agent for Medullary Carcinoma of the Thyroid
Hitoya Ohta, Kazutaka Yamamoto, Keigo Endo, Toru Mori, Daisaburo Hamanaka, Akira Shimazu, Katsuji Ikekubo, Kazuo Makimoto, Yasuhiro Lida, Junji Konishi, Rikushi Morita, Naotaka Hata, Kazuko Horiuchi, Akira Yokoyama, Kanji Torizuka, Kanji Kuma
Journal of Nuclear Medicine Mar 1984, 25 (3) 323-325;
A New Imaging Agent for Medullary Carcinoma of the Thyroid
Hitoya Ohta, Kazutaka Yamamoto, Keigo Endo, Toru Mori, Daisaburo Hamanaka, Akira Shimazu, Katsuji Ikekubo, Kazuo Makimoto, Yasuhiro Lida, Junji Konishi, Rikushi Morita, Naotaka Hata, Kazuko Horiuchi, Akira Yokoyama, Kanji Torizuka, Kanji Kuma
Journal of Nuclear Medicine Mar 1984, 25 (3) 323-325;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer
- 99Tcm(V)DMSA scintigraphy in skeletal metastases and superscans arising from various malignancies: diagnosis, treatment monitoring and therapeutic implications
- Diagnostic Value of 99mTc-Methylene Diphosphonate and 99mTc-Pentavalent DMSA Compared with 99mTc-Sestamibi for Palpable Breast Lesions